Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,748,841
+$13,602,340 QoQ
Shares Held
310,617
+170.5% QoQ
Ownership
0.321%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#62
of 314 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. XENE ranks #13 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in XENE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,748,841 | 310,617 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $5,146,501 | 114,826 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $928,227 | 23,119 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,951,492 | 62,348 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $297,045 | 6,900 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $631,960 | 18,500 | Principal | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||